In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong cash runway.

Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and memory.

Musculoskeletal disorders are a primary cause of disability worldwide, especially in aging societies like Japan. As individuals age, reductions in muscle mass and physical activity weaken the body's ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults. Recently, there has been growing interest in the potential role of diet in the ...